181
Participants
Start Date
April 19, 2021
Primary Completion Date
August 31, 2022
Study Completion Date
March 15, 2023
AcrySof IQ PanOptix Presbyopia Correcting IOL
UV and blue-light filtering foldable multifocal IOL with a +2.17 diopter (D) addition power of intermediate visual acuity and a +3.25 D addition power of near visual acuity. This device is approved in China.
Cataract surgery
Cataract extraction by phacoemulsification, followed by implantation of the AcrySof IQ PanOptix Presbyopia Correcting IOL
Peking University People's Hospital, Beijing
Beijing Tongren Hospital Capital Medical University, Beijing
Eye & ENT Hospital of Fudan University, Shanghai
Ophthalmic Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Shandong
Tianjin Medical University Eye Hospital, Tianjin
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guandong
West China Hospital of Sichuan University, Sichuan
Shanxi Eye Hospital, Shanxi
Lead Sponsor
Alcon Research
INDUSTRY